Barecetamab

• Target :

  EGFR

• Related Pathways :

  Angiogenesis|||Tyrosine Kinase/Adaptors|||JAK/STAT signaling

• Purity :

  0.971

• Bioactivity :

  Barecetamab (ISU-104) is a humanized monoclonal antibody against tyrosine protein kinase ErbB3 with anticancer activity for use in investigational stage malignant solid tumors.

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  2275727-74-5